HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation
NYSE:DOC • US42250P1030
Current stock price
16.735 USD
+0.21 (+1.3%)
Last:
This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DOC Profitability Analysis
1.1 Basic Checks
- In the past year DOC was profitable.
- In the past year DOC had a positive cash flow from operations.
- Each year in the past 5 years DOC has been profitable.
- DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- DOC's Return On Assets of 0.35% is in line compared to the rest of the industry. DOC outperforms 47.54% of its industry peers.
- With a Return On Equity value of 0.94%, DOC perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- With a Return On Invested Capital value of 2.24%, DOC perfoms like the industry average, outperforming 40.98% of the companies in the same industry.
- DOC had an Average Return On Invested Capital over the past 3 years of 2.27%. This is in line with the industry average of 3.11%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- With a Profit Margin value of 2.50%, DOC perfoms like the industry average, outperforming 46.72% of the companies in the same industry.
- In the last couple of years the Profit Margin of DOC has declined.
- DOC has a Operating Margin of 19.31%. This is comparable to the rest of the industry: DOC outperforms 46.72% of its industry peers.
- DOC's Operating Margin has improved in the last couple of years.
- DOC has a worse Gross Margin (60.00%) than 68.03% of its industry peers.
- In the last couple of years the Gross Margin of DOC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. DOC Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
- Compared to 1 year ago, DOC has less shares outstanding
- Compared to 5 years ago, DOC has more shares outstanding
- DOC has a worse debt/assets ratio than last year.
2.2 Solvency
- DOC has an Altman-Z score of 0.32. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
- DOC has a Altman-Z score (0.32) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.27 is on the high side and indicates that DOC has dependencies on debt financing.
- DOC has a Debt to Equity ratio (1.27) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.32 |
ROIC/WACC0.38
WACC5.96%
2.3 Liquidity
- DOC has a Current Ratio of 0.48. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.48, DOC is not doing good in the industry: 74.59% of the companies in the same industry are doing better.
- A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC has a worse Quick ratio (0.48) than 74.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. DOC Growth Analysis
3.1 Past
- DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
- DOC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.06% yearly.
- Looking at the last year, DOC shows a small growth in Revenue. The Revenue has grown by 4.52% in the last year.
- DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- DOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.77% yearly.
- Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. DOC Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 47.81, DOC can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Earnings ratio as DOC.
- Compared to an average S&P500 Price/Earnings ratio of 26.17, DOC is valued quite expensively.
- Based on the Price/Forward Earnings ratio of 77.07, the valuation of DOC can be described as expensive.
- DOC's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of DOC to the average of the S&P500 Index (23.05), we can say DOC is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.81 | ||
| Fwd PE | 77.07 |
4.2 Price Multiples
- DOC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOC is cheaper than 61.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.01 |
4.3 Compensation for Growth
- A cheap valuation may be justified as DOC's earnings are expected to decrease with -9.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
5. DOC Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 7.35%, DOC is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 8.03, DOC pays a bit more dividend than its industry peers.
- DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.35% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Fundamentals: All Metrics, Ratios and Statistics
NYSE:DOC (4/6/2026, 12:12:03 PM)
16.735
+0.21 (+1.3%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.68%
Inst Owner Change0%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap11.64B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.83 (18.49%)
Short Float %4.29%
Short Ratio3.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.35% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)0%
PT rev (3m)-4.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.81 | ||
| Fwd PE | 77.07 | ||
| P/S | 4.12 | ||
| P/FCF | N/A | ||
| P/OCF | 9.29 | ||
| P/B | 1.55 | ||
| P/tB | 1.72 | ||
| EV/EBITDA | 13.01 |
EPS(TTM)0.35
EY2.09%
EPS(NY)0.22
Fwd EY1.3%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY10.76%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | N/A |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 130.74% | ||
| Cap/Sales | 49.05% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.32 |
F-Score6
WACC5.96%
ROIC/WACC0.38
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.56%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
How profitable is HEALTHPEAK PROPERTIES INC (DOC) stock?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
Can you provide the financial health for DOC stock?
The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 1 / 10.
Is the dividend of HEALTHPEAK PROPERTIES INC sustainable?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.